首页|肠道屏障功能血清检测指标异常与代谢性疾病的相关性研究

肠道屏障功能血清检测指标异常与代谢性疾病的相关性研究

扫码查看
目的 探讨肠道屏障功能血清检测指标异常与代谢性疾病的相关性。方法 选取2020年1月至2023年8月于该院体检中心接受肠道屏障功能血清检测的26 838例体检者为研究对象。根据D-乳酸(DLC)、细菌内毒素(BT)及二胺氧化酶(DAO)是否异常进行分组。收集DLC、BT、DAO异常体检者的临床资料,包括体重、血压[收缩压(SBP)与舒张压(DBP)]、空腹血糖(GLU)、脉率、总胆红素(TBIL)、直接胆红素(DBIL)、间接胆红素(IBIL)、总蛋白(TP)、ALT、AST、人血浆蛋白磷脂酶(Lp-PLA2)等指标;统计DLC、BT、DAO异常体检者脂肪肝的发生率,分析DLC、BT、DAO水平与脂肪肝发生的相关性。结果 26 838例体检者中 DLC 异常 544 例(2。03%),BT 异常 927 例(3。45%),DAO 异常 649 例(2。42%)。DLC、BT、DAO 异常人群中,男性检出率明显高于女性,且多伴随肥胖、血压增高和血糖升高。68。08%的BT异常者SBP偏高,51。02%的DBP偏高,40。72%的GLU偏高。99。58%的DLC异常者IBIL异常。血清检测指标DLC、BT、DAO异常人群中脂肪肝发生率较高,分别为43。57%、44。77%、38。83%。Spearman秩相关性分析显示,DLC、BT、DAO水平与脂肪肝的发生相关(P<0。05)。结论 DLC、BT、DA O水平可能早期预警代谢紊乱引起的高血压、糖尿病、肝功能损伤,并可预示脂肪肝的发生风险。
Correlation between abnormal serum detection indicators of intestinal barrier function with metabolic diseases
Objective To explore the correlation between serum detection indicators abnormality of in-testinal barrier function with metabolic diseases.Methods A total of 26 838 individuals undergoing serum de-tection of intestinal barrier function in the physical examination center of this hospital from January 2020 to August 2023 were selected as the study subjects and grouped based on whether D-lactic acid(DLC),bacterial endotoxin(BT)and diamine oxidase(DAO)were abnormal.Their clinical data of the patients with abnormal DLC,BT and DAO were collected,including the body weight,blood pressure[systolic blood pressure(SBP)and diastolic blood pressure(DBP)],fasting blood glucose(GLU),pulse rate,total bilirubin(TBIL),direct bilirubin(DBIL),indirect bilirubin(IBIL),total protein(TP),alanine aminotransferase(ALT),aspartate aminotransferase(AST),and human plasma protein phospholipase(Lp-PLA2),etc.;the incidence rate of fat-ty liver in the subjects with abnormal DLC,BT and DAO was statistically analyzed,and the correlation be-tween abnormal DLC,BT and DAO with the fatty liver occurrence was analyzed.Results Among the 26 838 individuals undergoing physical examination,there were 544 cases(2.03%)of abnormal DLC,927 cases(3.45%)of abnormal BT and 649 cases(2.42%)of abnormal DAO.In the populations with abnormal DLC,BT and DAO,the detection rate in the male patients was significantly higher than that in the females,moreo-ver which were often accompanied by obesity,increased blood pressure and elevated blood sugar.68.08%of the patients with abnormal BT had high SBP,51.02%of the patients had high DBP,and 40.72%of the pa-tients had high GLU.99.58%of patients with abnormal DLC had abnormal IBIL.The population with abnor-mal serum DLC,BT and DAO had the high incidence rate of fatty liver,which were 43.57%,44.77%and 38.83%,respectively.The Spearman's rank correlation analysis showed that the DLC,BT and DAO levels were correlated with the occurrence of fatty liver(P<0.05).Conclusion The DLC,BT and DAO levels could early warn hypertension,diabetes and liver function damage caused by metabolic disorders,and predict the risk of fatty liver occurrence.

D-lactic acidbacterial endotoxindiamine oxidasemetabolic diseasefatty liver

黄莉、鲁涛、张亚兰、陈宗涛

展开 >

陆军军医大学第一附属医院健康管理科,重庆 400038

D-乳酸 细菌内毒素 二胺氧化酶 代谢性疾病 脂肪肝

2024

重庆医学
重庆市卫生信息中心,重庆市医学会

重庆医学

CSTPCD
影响因子:1.797
ISSN:1671-8348
年,卷(期):2024.53(24)